阿奇霉素治疗小儿支原体肺炎的临床分析

Clinical Analysis of Azithromycin in the Treatment of Mycoplasma Pneumonia in Children

目的探讨分析阿奇霉素对小儿支原体肺炎患者的疗效。方法随机选取2013年12月—2015年12月来该院就诊的300例支原体肺炎患儿依照不同治疗措施进行分组,A组实施阿奇霉素治疗方式(150例),B组实施红霉素治疗方式(150例)。结果 A组小儿支原体肺炎患者治疗有效率明显高于B组,不良反应率明显低于B组(P<0.05)。差异有统计学意义。结论和红霉素相比,阿奇霉素应用于小儿支原体肺炎患者,有着相对更高的治疗有效率和相对更低的不良反应率,治疗成效更为明显,值得进行更深层次的研究。

Objective To investigate the effect of azithromycin on children with Mycoplasma pneumonia. Methods In December 2013- December 2015, 300 cases of children with mycoplasma pneumonia of our hospital were randomly selected,and in accordance with the different treatment measures,they were divided into groups, A group of the implementation of azithromycin treatment（150 cases）, B group of erythromycin treatment（150 cases）. Results The effective rate of A group of children with mycoplasma pneumonia was significantly higher than that of B group, adverse reaction rate was significantly lower than B group（P〈0.05）. Conclusion Compared to erythromycin, azithromycin in mycoplasma pneumonia patients, relatively higher effective rate of treatment and lower rate of adverse reactions, treatment effect is more obvious, worthy of deeper study.